Centre For Clinical Studies/Nucleus Network
Nucleus Network has been Australia's leading early phase clinical research organisation since establishment in 2003.
Nucleus Network has two clinical sites: the AMREP Centre for Clinical Studies (a 41-bed early phase clinical trial unit co-located with the Alfred Medical Research Education Precinct at the Alfred Hospital), the Austin Centre for Clinical Studies.
Australia provides an expedited regulatory pathway, the CTN scheme, for the initiation of first-in-human clinical trials without the need for filing an IND.
Consequently, we primarily service a global client base.
We are a not-for-profit organisation, wholly owned by the Baker IDI Heart and Diabetes Institute , allowing reinvestment into the business to support quality clinical outcomes.
Services We Offer
Our experienced clinical research team can help you assess safety, identify risks and clarify your early stage development path. We have strong expertise to help to:
- Assist you to accelerate proof of concept
- Establish dose escalation regimens
- Access our extensive network to support study-specific pharmacodynamics (PD) requirements
- Undertake specialist studies, such as ethno-pharmacology, TQT, ADME, drug interaction
- Adhere to globally consistent quality standards for patient safety and regulatory guidelines